跳至主要内容
临床试验/JPRN-UMIN000020395
JPRN-UMIN000020395已完成未知

A study to evaluate the usefulness of contrast medium 'Sonazoid; Perflubutane' in EUS diagnosis for pancreaticobiliary tumors. - Usefulness of contrast medium Sonazoid in EUS diagnosis for pancreaticobiliary tumors.

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine. Kansai Medical University Hirakata Hospital0 个研究点目标入组 100 人开始时间: 2016年1月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Cases under 20 years old Cases without written informed consent Cases with allergy for Sonazoid; Perflubutane Cases with possibility of pregnant Cases considered ineligible for this study

研究者

发起方
Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine. Kansai Medical University Hirakata Hospital

相似试验